ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,667.56
0.08%
Dow Jones
41,985.35
0.08%
US Dollar vs MXN
20.2392
0.00%
Brent Oil
71.775
0.00%
Bitcoin
84,352.18
0.36%
Pepperstone
Advertisement
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Mersana Therapeutics Inc (MRSN)

  7. Mersana Therapeutics Inc (MRSN) Noticias

MRSN

Mersana Therapeutics (MRSN)

Mersana Therapeutics Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:MRSN
FechaHoraFuenteTítuloSímboloCompañía
03/03/202507:50Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:MRSNMersana Therapeutics Inc
03/03/202506:27Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MRSNMersana Therapeutics Inc
03/03/202506:01GlobeNewswire Inc.Mersana Therapeutics Provides Business Update and Announces Fourth Quarter and Full Year 2024 Financial ResultsNASDAQ:MRSNMersana Therapeutics Inc
25/02/202507:00GlobeNewswire Inc.Mersana Therapeutics to Present at Upcoming Investor ConferencesNASDAQ:MRSNMersana Therapeutics Inc
24/02/202515:01GlobeNewswire Inc.Mersana Therapeutics to Host Fourth Quarter and Year End 2024 Conference Call on March 3, 2025NASDAQ:MRSNMersana Therapeutics Inc
14/02/202517:15Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:MRSNMersana Therapeutics Inc
30/01/202507:00GlobeNewswire Inc.Mersana Therapeutics to Participate in the Guggenheim SMID Cap Biotech ConferenceNASDAQ:MRSNMersana Therapeutics Inc
17/01/202518:27Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MRSNMersana Therapeutics Inc
17/01/202518:05Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:MRSNMersana Therapeutics Inc
14/01/202515:10Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:MRSNMersana Therapeutics Inc
10/01/202505:02GlobeNewswire Inc.Mersana Therapeutics Announces Additional FDA Fast Track Designation Granted to Emiltatug Ledadotin (XMT-1660)NASDAQ:MRSNMersana Therapeutics Inc
10/01/202505:00GlobeNewswire Inc.Mersana Therapeutics Announces Positive Initial Clinical Data from Phase 1 Clinical Trial of Emiltatug Ledadotin (XMT-1660); Initiation of Expansion in Triple Negative Breast CancerNASDAQ:MRSNMersana Therapeutics Inc
15/11/202415:45Edgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:MRSNMersana Therapeutics Inc
14/11/202416:45Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:MRSNMersana Therapeutics Inc
13/11/202410:00AllPennyStocks.comThis Particular Biotech Stock Is Soaring On Two Key AnnouncementsNASDAQ:MRSNMersana Therapeutics Inc
13/11/202407:50Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MRSNMersana Therapeutics Inc
13/11/202406:00GlobeNewswire Inc.Mersana Therapeutics Provides Business Update and Announces Third Quarter 2024 Financial ResultsNASDAQ:MRSNMersana Therapeutics Inc
06/11/202407:00GlobeNewswire Inc.Mersana Therapeutics to Host Third Quarter 2024 Conference Call on November 13, 2024NASDAQ:MRSNMersana Therapeutics Inc
13/08/202406:00GlobeNewswire Inc.Mersana Therapeutics Provides Business Update and Announces Second Quarter 2024 Financial ResultsNASDAQ:MRSNMersana Therapeutics Inc
06/08/202407:00GlobeNewswire Inc.Mersana Therapeutics to Host Second Quarter 2024 Conference Call on August 13, 2024NASDAQ:MRSNMersana Therapeutics Inc
17/05/202407:26Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:MRSNMersana Therapeutics Inc
09/05/202423:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:MRSNMersana Therapeutics Inc
09/05/202416:06Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:MRSNMersana Therapeutics Inc
09/05/202405:59GlobeNewswire Inc.Mersana Therapeutics Provides Business Update and Announces First Quarter 2024 Financial ResultsNASDAQ:MRSNMersana Therapeutics Inc
03/05/202415:30GlobeNewswire Inc.Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:MRSNMersana Therapeutics Inc
02/05/202407:00GlobeNewswire Inc.Mersana Therapeutics to Host First Quarter 2024 Conference Call on May 9, 2024NASDAQ:MRSNMersana Therapeutics Inc
28/02/202415:05Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:MRSNMersana Therapeutics Inc
28/02/202407:43Edgar (US Regulatory)Form POSASR - Post-effective Amendment to an automatic shelf registration statementNASDAQ:MRSNMersana Therapeutics Inc
28/02/202406:00GlobeNewswire Inc.Mersana Therapeutics Provides Business Update and Announces Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:MRSNMersana Therapeutics Inc
21/02/202407:00GlobeNewswire Inc.Mersana Therapeutics to Host Fourth Quarter and Year End 2023 Conference Call on February 28, 2024NASDAQ:MRSNMersana Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:MRSN

Su Consulta Reciente

COIN
MBNNUSD
Mobilian
NASDAQ
ABLPFXX
Jpmorgan Chase Financial...
COIN
AMLTUSD
AMLT Token
EU
FGINP
Euronext Top 30 France G...
COIN
ABSTBTC
Abitshadow Token
POLO
ZRXUSDT
0x protocol
COIN
BCDCETH
BCDC
COIN
0XMRUSD
0xMonero
EU
DEAM
Essonne department de L ...
BITMOT
21755
Btp-1nv29 5,25%
NASDAQ
FEVNX
Bmo Us Equity Fund Serie...
EU
ATOAG
Atos SE Atos Se bond unt...
GATE
POOLZUSDT
$Poolz Finance
NASDAQ
FDQDX
Bmo Global Small Cap Fun...
NASDAQ
CAUYX
Chou Associates Fund Ser...
COIN
INXTUSD
Internxt
Delayed Upgrade Clock
ADVFN Logo
México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2025 ADVFN PLC - Todos los derechos reservados

Quitar anuncios

Suscríbete a una experiencia sin publicidad

Sin anuncios

Pruébalo ahora

Mantenga los anuncios